baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

GARO AB/ SE0015812417 /

10/06/2024 12:31:36	Chg. -0.020	Volume	Bid15:49:33	Ask15:49:33	High	Low
2.625EUR	-0.76%	0 Turnover: 0.000	2.640Bid Size: 2,100	2.710Ask Size: 2,100	2.660	2.625

GlobeNewswire 07/03/2022 Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 S...

GlobeNewswire 17/11/2021 Agenus to Participate in 4th Annual Evercore ISI HealthCONx Conference

GlobeNewswire 16/11/2021 Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

GlobeNewswire 09/11/2021 Agenus Corporate Update and Third Quarter 2021 Financial Report

GlobeNewswire 22/10/2021 Agenus Provides Update on Balstilimab Development

GlobeNewswire 10/09/2021 New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Gi...

GlobeNewswire 17/08/2021 Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update

GlobeNewswire 09/08/2021 Agenus Corporate Update and Second Quarter 2021 Financial Report

GlobeNewswire 10/07/2021 Agenus Acquires 120 Acres in the Heart of the California Biomanufacturing Center in Vacaville

GlobeNewswire 06/07/2021 Agenus Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for Partnered Anti...

GlobeNewswire 18/05/2021 Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific ...

GlobeNewswire 06/05/2021 Agenus Corporate Update and First Quarter 2021 Financial Report

GlobeNewswire 15/03/2021 Progress Software to Report First Quarter Financial Results on March 25, 2021

GlobeNewswire 15/03/2021 Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report

GlobeNewswire 09/02/2021 Andy Hurley Named Agenus Chief Commercial Officer

GlobeNewswire 04/02/2021 Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19

GlobeNewswire 14/01/2021 Progress Reports 2020 Fiscal Fourth Quarter and Year End Results

GlobeNewswire 04/01/2021 Progress Software to Report Financial Results for Fiscal Fourth Quarter and Fiscal 2020 on January 1...

GlobeNewswire 16/12/2020 Dr. Maurizio Fava of Massachusetts General Hospital to Serve as Principal Investigator for PT00114 C...

GlobeNewswire 10/11/2020 An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2

GlobeNewswire 05/11/2020 Dr. Steven O’Day Named Agenus Chief Medical Officer

GlobeNewswire 02/11/2020 Agenus Doses First COVID-19 Patient with iNKT Cell Therapy

GlobeNewswire 13/10/2020 Susan Hirsch Joins Agenus’ Board of Directors

GlobeNewswire 29/09/2020 Progress Announces Third Quarter 2020 Financial Results

GlobeNewswire 22/09/2020 Progress Software Announces Details for Fiscal Third Quarter Earnings Release and Conference Call

GARO AB/ SE0015812417 /

If you wish to receive reply to your feedback, please provide your email address.